{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:04:53Z","timestamp":1785359093224,"version":"3.55.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s11910-022-01240-4","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T03:03:07Z","timestamp":1668481387000},"page":"823-837","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-6095","authenticated-orcid":false,"given":"Guillaume","family":"Lamotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sandroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/B978-0-444-64032-1.00027-8","volume":"160","author":"CH Gibbons","year":"2019","unstructured":"Gibbons CH. Basics of autonomic nervous system function. Handb Clin Neurol. 2019;160:407\u201318.","journal-title":"Handb Clin Neurol"},{"key":"1240_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/B978-0-444-53480-4.00006-0","volume":"126","author":"R Freeman","year":"2014","unstructured":"Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014;126:63\u201379.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"1240_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/mus.27048","volume":"63","author":"D Kaur","year":"2021","unstructured":"\u2022 Kaur D, Tiwana H, Stino A, Sandroni P. Autonomic neuropathies. Muscle Nerve. 2021;63(1):10\u201321. This is an excellent review which categorizes peripheral autonomic neuropathies based on their acute\/subacute or chronic onset.","journal-title":"Muscle Nerve"},{"issue":"5","key":"1240_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/WCO.0000000000000962","volume":"34","author":"G Lamotte","year":"2021","unstructured":"\u2022 Lamotte G, Sandroni P. A practical approach to peripheral autonomic neuropathies. Curr Opin Neurol. 2021;34(5):638\u201347. This review focuses on the practical approach of individuals with peripheral autonomic neuropathies with an emphasis on the autonomic history and physical examination.","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"1240_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10286-017-0425-7","volume":"27","author":"DS Goldstein","year":"2017","unstructured":"Goldstein DS, Cheshire WP Jr. The autonomic medical history. Clin Auton Res. 2017;27(4):223\u201333.","journal-title":"Clin Auton Res"},{"issue":"2","key":"1240_CR6","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.clinph.2020.11.024","volume":"132","author":"WP Cheshire","year":"2021","unstructured":"\u2022\u2022 Cheshire WP, Freeman R, Gibbons CH, et al. Electrodiagnostic assessment of the autonomic nervous system: a consensus statement endorsed by the American Autonomic Society, American Academy of Neurology, and the International Federation of Clinical Neurophysiology. Clin Neurophysiol. 2021;132(2):666\u201382. This is the most recent consensus statement on autonomic testing.","journal-title":"Clin Neurophysiol"},{"key":"1240_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ana.410140513","volume":"14","author":"PA Low","year":"1983","unstructured":"Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol. 1983;14:573\u201380.","journal-title":"Ann Neurol"},{"issue":"1","key":"1240_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/00004691-199301000-00003","volume":"10","author":"PA Low","year":"1993","unstructured":"Low PA. Autonomic nervous system function. J Clin Neurophysiol. 1993;10(1):14\u201327.","journal-title":"J Clin Neurophysiol"},{"issue":"3","key":"1240_CR9","first-page":"392","volume":"31","author":"TG Pickering","year":"1969","unstructured":"Pickering TG, Sleight P. Quantitative index of baroreflex activity in normal and hypertensive subjects using Valsalva\u2019s manoeuvre. Br Heart J. 1969;31(3):392.","journal-title":"Br Heart J"},{"key":"1240_CR10","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1212\/01.wnl.0000184504.13173.ef","volume":"65","author":"ER Vogel","year":"2005","unstructured":"Vogel ER, Sandroni P, Low PA. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure. Neurology. 2005;65:1533\u20137.","journal-title":"Neurology"},{"issue":"3","key":"1240_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.25170","volume":"83","author":"L Norcliffe-Kaufmann","year":"2018","unstructured":"\u2022\u2022 Norcliffe-Kaufmann L, Kaufmann H, Palma JA, et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies. Ann Neurol. 2018;83(3):522\u201331. This important study validated the ratio of orthostatic heart rate changes over systolic blood pressure changes to identify individuals with neurogenic orthostatic hypotension.","journal-title":"Ann Neurol"},{"issue":"6","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/ana.25363","volume":"84","author":"P Balagny","year":"2018","unstructured":"Balagny P, Wanono R, d\u2019Ortho MP, Vidal-Petiot E. Reply to validation of the new diagnostic tests for neurogenic orthostatic hypotension. Ann Neurol. 2018;84(6):957\u20138.","journal-title":"Ann Neurol"},{"issue":"6","key":"1240_CR13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0025-6196(12)65338-5","volume":"64","author":"RD Fealey","year":"1989","unstructured":"Fealey RD, Low PA, Thomas JE. Thermoregulatory sweating abnormalities in diabetes mellitus. Mayo Clin Proc. 1989;64(6):617\u201328.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.26018","volume":"89","author":"S Koay","year":"2021","unstructured":"\u2022\u2022 Koay S, Vichayanrat E, Bremner F, et al. Multimodal biomarkers quantify recovery in autoimmune autonomic ganglionopathy. Ann Neurol. 2021;89(4):753\u201368. This study demonstrated the role of quantitative autonomic function testing to monitor the response to treatment in individuals with autoimmune autonomic ganglionopathy.","journal-title":"Ann Neurol"},{"key":"1240_CR15","first-page":"212","volume":"3","author":"D Robertson","year":"1993","unstructured":"Robertson D, Hollister AS, Biaggioni I. Arterial baroreflex failure in man. Clin Auton Res. 1993;3:212.","journal-title":"Clin Auton Res"},{"issue":"3","key":"1240_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2506","volume":"12","author":"V Potockova","year":"2022","unstructured":"Potockova V, Mala S, Hoskovcova L, et al. Thermal quantitative sensory testing as a screening tool for cardiac autonomic neuropathy in patients with diabetes mellitus. Brain Behav. 2022;12(3): e2506.","journal-title":"Brain Behav"},{"issue":"1","key":"1240_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1161\/HYPERTENSIONAHA.121.17805","volume":"79","author":"G Lamotte","year":"2022","unstructured":"\u2022\u2022 Lamotte G, Coon EA, Suarez MD, et al. Standardized autonomic testing in patients with probable radiation-induced afferent baroreflex failure. Hypertension. 2022;79(1):50\u20136. This study described the pattern of autonomic dysfunction on standardized autonomic testing in patients with probable radiation-induced afferent baroreflex failure.","journal-title":"Hypertension"},{"issue":"4","key":"1240_CR18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/WNP.0000000000000627","volume":"38","author":"K Shouman","year":"2021","unstructured":"Shouman K, Sandroni P. Antibody testing for suspected autoimmune autonomic dysfunction and small fiber neuropathies. J Clin Neurophysiol. 2021;38(4):274\u20138.","journal-title":"J Clin Neurophysiol"},{"issue":"10","key":"1240_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.mayocp.2018.05.033","volume":"93","author":"JK Cutsforth-Gregory","year":"2018","unstructured":"Cutsforth-Gregory JK, McKeon A, Coon EA, et al. Ganglionic antibody level as a predictor of severity of autonomic failure. Mayo Clin Proc. 2018;93(10):1440\u20137.","journal-title":"Mayo Clin Proc"},{"key":"1240_CR20","doi-asserted-by":"publisher","unstructured":"\u2022 Karagiorgou K, Dandoulaki M, Mantegazza R, et al. Novel cell-based assay for alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy. Neurol Neuroimmunol Neuroinflamm. 2022;9(3):e1162. https:\/\/doi.org\/10.1212\/NXI.0000000000001162. Print 2022 May.","DOI":"10.1212\/NXI.0000000000001162"},{"key":"1240_CR21","doi-asserted-by":"crossref","unstructured":"Gibbons CH. A double-blind, placebo controlled trial of Gamunex-C in patient with small fiber neuropathy associated with autoantibodies to TS-HDS and FGFR3 (P8-13.002). Neurology. 2022;98(18 Supplement).","DOI":"10.1212\/WNL.98.18_supplement.2276"},{"issue":"9","key":"1240_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1371","volume":"9","author":"MA Gertz","year":"2019","unstructured":"Gertz MA, Mauermann ML, Grogan M, Coelho T. Advances in the treatment of hereditary transthyretin amyloidosis: a review. Brain Behav. 2019;9(9): e01371.","journal-title":"Brain Behav"},{"issue":"6","key":"1240_CR23","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","volume":"268","author":"D Adams","year":"2021","unstructured":"\u2022 Adams D, Ando Y, Beir\u00e3o JM, et al. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy. J Neurol. 2021;268(6):2109\u201322. This review outlines detailed recommendations to improve the diagnosis of ATTR amyloidosis with peripheral neuropathy.","journal-title":"J Neurol"},{"key":"1240_CR24","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Carroll A, Dyck PJ, de Carvalho M, et al. Novel approaches to diagnosis and management of hereditary transthyretin amyloidosis. J Neurol, Neurosurg Psychiatr 2022. This review highlights the key advances in the diagnostic techniques, current and emerging management strategies, and biomarker development for disease progression in hereditary transthyretin amyloidosis.","DOI":"10.1136\/jnnp-2021-327909"},{"issue":"Suppl 1","key":"1240_CR25","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/WCO.0000000000000289","volume":"29","author":"D Adams","year":"2016","unstructured":"Adams D, Suhr OB, Hund E, et al. First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Current opinion in neurology. 2016;29(Suppl 1):S14\u201326.","journal-title":"Current opinion in neurology"},{"issue":"24","key":"1240_CR26","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD, Maurer MS, Falk RH, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133(24):2404\u201312.","journal-title":"Circulation"},{"issue":"2","key":"1240_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1001\/archneurol.2010.261","volume":"68","author":"CJ Klein","year":"2011","unstructured":"Klein CJ, Vrana JA, Theis JD, et al. Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol. 2011;68(2):195\u20139.","journal-title":"Arch Neurol"},{"issue":"3","key":"1240_CR28","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cjp2.126","volume":"5","author":"T Rezk","year":"2019","unstructured":"Rezk T, Gilbertson JA, Mangione PP, et al. The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis. J Pathol Clin Res. 2019;5(3):145\u201353.","journal-title":"J Pathol Clin Res"},{"issue":"Pt 10","key":"1240_CR29","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1093\/brain\/awu196","volume":"137","author":"TY Wu","year":"2014","unstructured":"Wu TY, Taylor JM, Kilfoyle DH, et al. Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia \u201cCANVAS\u201d syndrome. Brain. 2014;137(Pt 10):2649\u201356.","journal-title":"Brain"},{"key":"1240_CR30","doi-asserted-by":"crossref","unstructured":"Beijer D, Dohrn MF, De Winter J, et al. RFC1 repeat expansions: a recurrent cause of sensory and autonomic neuropathy with cough and ataxia. Eur J Neurol. 2022;29(7):2156\u201361.","DOI":"10.1111\/ene.15310"},{"issue":"3","key":"1240_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11916-011-0181-7","volume":"15","author":"A Hovaguimian","year":"2011","unstructured":"Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep. 2011;15(3):193\u2013200.","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"1240_CR32","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/ene.12842","volume":"23","author":"V Provitera","year":"2016","unstructured":"Provitera V, Gibbons CH, Wendelschafer-Crabb G, et al. A multi-center, multinational age- and gender-adjusted normative dataset for immunofluorescent intraepidermal nerve fiber density at the distal leg. Eur J Neurol. 2016;23(2):333\u20138.","journal-title":"Eur J Neurol"},{"issue":"Pt 7","key":"1240_CR33","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/brain\/awh180","volume":"127","author":"CT Shun","year":"2004","unstructured":"Shun CT, Chang YC, Wu HP, et al. Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain. 2004;127(Pt 7):1593\u2013605.","journal-title":"Brain"},{"issue":"7","key":"1240_CR34","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/brain\/awaa163","volume":"143","author":"G Baskozos","year":"2020","unstructured":"Baskozos G, Sandy-Hindmarch O, Clark AJ, et al. Molecular and cellular correlates of human nerve regeneration: ADCYAP1\/PACAP enhance nerve outgrowth. Brain. 2020;143(7):2009\u201326.","journal-title":"Brain"},{"issue":"6","key":"1240_CR35","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S1474-4422(14)70024-9","volume":"13","author":"DL Bennett","year":"2014","unstructured":"Bennett DL, Woods CG. Painful and painless channelopathies. The Lancet Neurology. 2014;13(6):587\u201399.","journal-title":"The Lancet Neurology"},{"issue":"11","key":"1240_CR36","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/cup.14070","volume":"48","author":"B Wu","year":"2021","unstructured":"Wu B, Pak DM, Smith KD, Shinohara MM. Utility of abdominal skin punch biopsy for detecting systemic amyloidosis. J Cutan Pathol. 2021;48(11):1342\u20136.","journal-title":"J Cutan Pathol"},{"issue":"18","key":"1240_CR37","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1212\/WNL.0b013e3182a9f449","volume":"81","author":"N Wang","year":"2013","unstructured":"Wang N, Gibbons CH, Lafo J, Freeman R. alpha-Synuclein in cutaneous autonomic nerves. Neurology. 2013;81(18):1604\u201310.","journal-title":"Neurology"},{"issue":"4","key":"1240_CR38","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/acn3.51347","volume":"8","author":"TD Levine","year":"2021","unstructured":"\u2022 Levine TD, Bellaire B, Gibbons C, Freeman R. Cutaneous alpha-synuclein deposition in postural tachycardia patients. Ann Clin Transl Neurol. 2021;8(4):908\u201317. In this study, a subgroup of patients with postural tachycardia had evidence of cutaneous alpha-synuclein deposition.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1240_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10286-022-00867-0","volume":"32","author":"MG Miglis","year":"2022","unstructured":"\u2022 Miglis MG, Seliger J, Shaik R, Gibbons CH. A case series of cutaneous phosphorylated \u03b1-synuclein in Long-COVID POTS. Clin Auton Res: Off J Clin Auton Res Soc. 2022;32(3):209\u201312. In this research letter, the authors report phosphorylated alpha-synuclein in skin biopsy samples in five young patients with long-COVID postural tachycardia syndrome.","journal-title":"Clin Auton Res: Off J Clin Auton Res Soc"},{"key":"1240_CR40","doi-asserted-by":"crossref","unstructured":"Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest vesrion. Circ J. 2012;76(2):508\u201319.","DOI":"10.1253\/circj.CJ-88-0020"},{"issue":"7","key":"1240_CR41","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010161","volume":"8","author":"HA Lodhi","year":"2019","unstructured":"Lodhi HA, Peri-Okonny PA, Schesing K, et al. Usefulness of blood pressure variability indices derived from 24-hour ambulatory blood pressure monitoring in detecting autonomic failure. J Am Heart Assoc. 2019;8(7): e010161.","journal-title":"J Am Heart Assoc"},{"issue":"6578","key":"1240_CR42","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.abm2052","volume":"375","author":"S Spudich","year":"2022","unstructured":"\u2022\u2022 Spudich S, Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267\u20139. This is an excellent review of the neurological complications of COVID-19.","journal-title":"Science"},{"key":"1240_CR43","unstructured":"Goldstein DS. Principles of Autonomic Medicine.\u00a0https:\/\/neuroscience.nih.gov\/publications\/Principles%20of%20Autonomic%20Medicine%20v.%202.1.pdf2020. Accessed 1 Nov 2022."},{"issue":"4","key":"1240_CR44","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10286-020-00714-0","volume":"30","author":"DS Goldstein","year":"2020","unstructured":"Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res: Off J Clin Auton Res Soc. 2020;30(4):299\u2013315.","journal-title":"Clin Auton Res: Off J Clin Auton Res Soc"},{"key":"1240_CR45","doi-asserted-by":"publisher","first-page":"100276","DOI":"10.1016\/j.ensci.2020.100276","volume":"21","author":"P Novak","year":"2020","unstructured":"Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. eNeurologicalSci. 2020;21:100276.","journal-title":"eNeurologicalSci"},{"issue":"2","key":"1240_CR46","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10286-021-00783-9","volume":"31","author":"G Lamotte","year":"2021","unstructured":"Lamotte G, Benarroch EE, Coon EA. Paroxysmal hypothermia and hyperhidrosis with exacerbation after COVID-19 Infection. Clin Auton Res: Off J Clin Auton Res Soc. 2021;31(2):327\u20139.","journal-title":"Clin Auton Res: Off J Clin Auton Res Soc"},{"issue":"3","key":"1240_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.12691\/ajmcr-9-3-16","volume":"9","author":"Z Mostel","year":"2021","unstructured":"Mostel Z, Ayat P, Capric V, Trimmingham A, McFarlane SI. Guillain-Barr\u00e9 syndrome in a COVID-19 patient: a case report and review of management strategies. Am J Med Case Rep. 2021;9(3):198\u2013200.","journal-title":"Am J Med Case Rep"},{"issue":"3","key":"1240_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10286-021-00803-8","volume":"31","author":"K Shouman","year":"2021","unstructured":"\u2022\u2022 Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clinical autonomic research: official journal of the Clinical Autonomic Research Society. 2021;31(3):385\u201394. This case series demonstrated that abnormalities on autonomic testing were seen in the majority of patients with persistent symptoms following COVID-19 infection but were mild in most cases. The most common finding was orthostatic intolerance, often without objective hemodynamic abnormalities on testing.","journal-title":"Clinical autonomic research: official journal of the Clinical Autonomic Research Society"},{"issue":"18","key":"1240_CR49","doi-asserted-by":"publisher","first-page":"4269","DOI":"10.1113\/JP281888","volume":"599","author":"NL Stute","year":"2021","unstructured":"Stute NL, Stickford JL, Province VM, Augenreich MA, Ratchford SM, Stickford ASL. COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS-CoV-2. J Physiol. 2021;599(18):4269\u201385.","journal-title":"J Physiol"},{"issue":"3","key":"1240_CR50","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1177\/1526924817715463","volume":"27","author":"D Banerjee","year":"2017","unstructured":"Banerjee D, Roeker LE, Grogan M, et al. Outcomes of patients with familial transthyretin amyloidosis after liver transplantation. Prog Transplant. 2017;27(3):246\u201350.","journal-title":"Prog Transplant"},{"issue":"24","key":"1240_CR51","doi-asserted-by":"publisher","first-page":"9629","DOI":"10.1073\/pnas.1121005109","volume":"109","author":"CE Bulawa","year":"2012","unstructured":"Bulawa CE, Connelly S, Devit M, et al. Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade. Proc Natl Acad Sci U S A. 2012;109(24):9629\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"1240_CR52","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","volume":"260","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maia LF, da Silva AM, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol. 2013;260(11):2802\u201314.","journal-title":"J Neurol"},{"issue":"8","key":"1240_CR53","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","volume":"79","author":"T Coelho","year":"2012","unstructured":"Coelho T, Maia LF, Martins da Silva A, et al. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology. 2012;79(8):785\u201392.","journal-title":"Neurology"},{"issue":"5","key":"1240_CR54","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1007\/s00415-016-8064-9","volume":"263","author":"A Cortese","year":"2016","unstructured":"Cortese A, Vita G, Luigetti M, et al. Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area. J Neurol. 2016;263(5):916\u201324.","journal-title":"J Neurol"},{"issue":"3","key":"1240_CR55","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1161\/HYPERTENSIONAHA.121.17454","volume":"78","author":"X Xia","year":"2021","unstructured":"Xia X, Wang R, Vetrano DL, et al. From normal cognition to cognitive impairment and dementia: impact of orthostatic hypotension. Hypertension. 2021;78(3):769\u201378.","journal-title":"Hypertension"},{"issue":"3","key":"1240_CR56","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.121.010573","volume":"15","author":"A Fedorowski","year":"2022","unstructured":"\u2022\u2022 Fedorowski A, Ricci F, Hamrefors V, et al. Orthostatic hypotension: management of a complex, but common, medical problem. Circ Arrhythm Electrophysiol. 2022;15(3): e010573. This is an excellent review focusing on a pathophysiological classification of orthostatic hypotension.","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"1240_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2020.102721","volume":"229","author":"JW Park","year":"2020","unstructured":"Park JW, Okamoto LE, Shibao CA, Biaggioni I. Pharmacologic treatment of orthostatic hypotension. Autonomic neuroscience\u202f: basic & clinical. 2020;229: 102721.","journal-title":"Autonomic neuroscience : basic & clinical"},{"issue":"16","key":"1240_CR58","doi-asserted-by":"publisher","first-page":"e1539","DOI":"10.1212\/WNL.0000000000006369","volume":"91","author":"JA Palma","year":"2018","unstructured":"Palma JA, Norcliffe-Kaufmann L, Martinez J, Kaufmann H. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension. Neurology. 2018;91(16):e1539\u201344.","journal-title":"Neurology"},{"issue":"4","key":"1240_CR59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/archneur.63.4.noc50340","volume":"63","author":"W Singer","year":"2006","unstructured":"Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol. 2006;63(4):513\u20138.","journal-title":"Arch Neurol"},{"issue":"1","key":"1240_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.107.089961","volume":"50","author":"C Shibao","year":"2007","unstructured":"Shibao C, Raj SR, Gamboa A, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50(1):47\u201353.","journal-title":"Hypertension"},{"issue":"2","key":"1240_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/HYPERTENSIONAHA.119.14483","volume":"78","author":"CA Shibao","year":"2021","unstructured":"Shibao CA, Palma JA, Celedonio JE, Martinez J, Kaufmann H, Biaggioni I. Predictors of the pressor response to the norepinephrine transporter inhibitor, atomoxetine, in neurogenic orthostatic hypotension. Hypertension. 2021;78(2):525\u201331.","journal-title":"Hypertension"},{"issue":"6","key":"1240_CR62","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/HYPERTENSIONAHA.114.04225","volume":"64","author":"CE Ramirez","year":"2014","unstructured":"Ramirez CE, Okamoto LE, Arnold AC, et al. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2014;64(6):1235\u201340.","journal-title":"Hypertension"},{"issue":"6","key":"1240_CR63","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10286-021-00827-0","volume":"31","author":"H Kaufmann","year":"2021","unstructured":"\u2022 Kaufmann H, Vickery R, Wang W, et al. Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. Clin Auton Res: Off J Clin Auton Res Soc. 2021;31(6):699\u2013711. This study demonstrated that ampreloxetine was well tolerated and improved orthostatic symptoms and seated\/standing blood pressure with little change in supine blood pressure. Further studies are necessary to investigate if ampreloxetine is beneficial for the treatment of neurogenic orthostatic hypotension in specific subgroups of patients.","journal-title":"Clin Auton Res: Off J Clin Auton Res Soc"},{"key":"1240_CR64","unstructured":"Theravance Biopharma, Inc. announces top-line results from a phase 3 study of ampreloxetine in patients with symptomatic neurogenic orthostatic hypotension [Press release]. 2021. https:\/\/wwwprnewswirecom\/news-releases\/theravance-biopharma-inc-announces-top-line-results-from-a-phase-3-study-of-ampreloxetine-in-patients-with-symptomatic-neurogenic-orthostatic-hypotension-301377200html. Accessed 1 Nov 2022."},{"issue":"1","key":"1240_CR65","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7326\/M20-4298","volume":"174","author":"SP Juraschek","year":"2021","unstructured":"\u2022\u2022 Juraschek SP, Hu JR, Cluett JL, et al. Effects of intensive blood pressure treatment on orthostatic hypotension: a systematic review and individual participant-based meta-analysis. Ann Intern Med. 2021;174(1):58\u201368. This systematic review and meta-analysis demonstrated that intensive blood pressure-lowering treatment decreases risk for orthostatic hypotension. Orthostatic hypotension, before or in the setting of more intensive blood pressure treatment, should not be viewed as a reason to avoid or de-escalate treatment for hypertension.","journal-title":"Ann Intern Med"},{"issue":"3","key":"1240_CR66","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","volume":"115","author":"AI Vinik","year":"2007","unstructured":"Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387\u201397.","journal-title":"Circulation"},{"issue":"4","key":"1240_CR67","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","volume":"28","author":"A Fanciulli","year":"2018","unstructured":"Fanciulli A, Jordan J, Biaggioni I, et al. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res: Off J Clin Auton Res Soc. 2018;28(4):355\u201362.","journal-title":"Clin Auton Res: Off J Clin Auton Res Soc"},{"key":"1240_CR68","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1161\/01.HYP.30.5.1062","volume":"30","author":"J Shannon","year":"1997","unstructured":"Shannon J, Jordan J, Costa F, Robertson RM, Biaggioni I. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30:1062\u20137.","journal-title":"Hypertension"},{"issue":"1","key":"1240_CR69","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.121.17111","volume":"78","author":"L Newman","year":"2021","unstructured":"\u2022\u2022 Newman L, O\u2019Connor JD, Romero-Ortuno R, Reilly RB, Kenny RA. Supine hypertension is associated with an impaired cerebral oxygenation response to orthostasis: finding from the Irish longitudinal study on ageing. Hypertension. 2021;78(1):210\u20139. This study demonstrated that in a large cohort of community-dwelling older adults, supine hypertension was associated with a larger drop and impaired recovery of cerebral oxygenation upon standing when standardized to orthostatic mean arterial pressure.","journal-title":"Hypertension"},{"issue":"8","key":"1240_CR70","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1097\/HJH.0000000000002078","volume":"37","author":"J Jordan","year":"2019","unstructured":"Jordan J, Fanciulli A, Tank J, et al. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. J Hypertens. 2019;37(8):1541\u20136.","journal-title":"J Hypertens"},{"issue":"7","key":"1240_CR71","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018979","volume":"10","author":"LE Okamoto","year":"2021","unstructured":"\u2022 Okamoto LE, Celedonio JE, Smith EC, et al. Local passive heat for the treatment of hypertension in autonomic failure. J Am Heart Assoc. 2021;10(7): e018979. This study demonstrated that local heat therapy effectively lowered overnight blood pressure in patients with autonomic failure and supine hypertension and offers a novel approach to treat this condition.","journal-title":"J Am Heart Assoc"},{"issue":"23","key":"1240_CR72","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1016\/j.jacc.2019.10.027","volume":"74","author":"I Biaggioni","year":"2019","unstructured":"Biaggioni I, Shibao CA, Diedrich A, Muldowney JAS 3rd, Laffer CL, Jordan J. Blood pressure management in afferent baroreflex failure: JACC review topic of the week. J Am Coll Cardiol. 2019;74(23):2939\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"1240_CR73","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/HYPERTENSIONAHA.120.15267","volume":"76","author":"L Norcliffe-Kaufmann","year":"2020","unstructured":"Norcliffe-Kaufmann L, Palma JA, Martinez J, Kaufmann H. Carbidopa for afferent baroreflex failure in familial dysautonomia: a double-blind randomized crossover clinical trial. Hypertension. 2020;76(3):724\u201331.","journal-title":"Hypertension"},{"issue":"6","key":"1240_CR74","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1464-5491.2010.03184.x","volume":"28","author":"AI Vinik","year":"2011","unstructured":"Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope? Diabet Med. 2011;28(6):643\u201351.","journal-title":"Diabet Med"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-022-01240-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-022-01240-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-022-01240-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T14:21:20Z","timestamp":1744208480000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-022-01240-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s11910-022-01240-4","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"5 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Guillaume Lamotte serves as the managing editor of the journal Clinical Autonomic Research. Paola Sandroni declares no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}]}}